NFKB1 and intestinal neoplasm: In this study, we analyzed the effect of DHMEQ administration on intestinal tumor formation to clarify whether the acceleration of intestinal carcinogenesis observed in HAI-1-deficient mice is associated with the activation of NF-κB signaling or not.